IP Library Assignment 073226/0963
Patent Assignment
Reel/Frame 073226/0963

Assignment of Assignor's Interest

Recorded: 2025-12-16 Pages: 9
Assignor
ZELGEN HOLDINGS LIMITED
Executed: 2025-12-12
Assignee
SUZHOU ZELGEN BIOPHARMACEUTICALS CO. LTD.
NO. 209, CHENFENG ROAD, KUNSHAN, CHINA
Covered Properties (34)
Trispecific Inhibitors for Cancer Treatment
Application: 62/312,965 →
Trispecific Inhibitors for Cancer Treatment
Application: 15/467,744 →
Publication: US 2017/0275353
Trispecific Inhibitors for Cancer Treatment
Application: 17/118,974 →
Publication: US 2021/0115123
Anti-Tigit Antagonists
Application: 62/442,642 →
Checkpoint Regulator Antagonists
Application: 15/858,963 →
Publication: US 2018/0185482
Anti-Pd-1 Antibodies, Antigen-Binding Portions Thereof and Checkpoint Regulator Antogonists Comprising the Same
Application: 16/696,253 →
Publication: US 2020/0164071
Checkpoint Regulator Antagonists
Application: 18/053,878 →
Publication: US 2023/0293684
Checkpoint Regulator Antagonists
Application: 19/220,711 →
Checkpoint Regulator Antagonists
Application: 62/691,658 →
Antitumor Antagonists
Application: 62/823,989 →
Trispecific Antagonists
Application: 16/457,343 →
Publication: US 2020/0002439
Trispecific Antagonists
Application: 16/845,924 →
Publication: US 2020/0277388
Trispecific Antagonists
Application: 16/995,414 →
Publication: US 2021/0009696
Antitumor Antagonists
Application: 16/457,399 →
Publication: US 2020/0002426
Antitumor Antagonists
Application: 17/301,869 →
Publication: US 2021/0246214
Antitumor Immune Checkpoint Regulator Antagonists
Application: 16/457,421 →
Publication: US 2020/0002417
A Bispecific Antagonist Comprising a Lag-3 Binding Domain
Application: 16/795,804 →
Publication: US 2020/0181272
A Bispecific Antagonist Comprising a Lag-3 Binding Domain
Application: 18/306,562 →
Publication: US 2023/0331857
Antitumor Immune Checkpoint Regulator Antagonists
Application: 19/285,411 →
Antitumor Antagonists
Application: 62/869,111 →
Antagonists Targeting the Tgf-B Pathway
Application: 16/706,187 →
Publication: US 2020/0231665
Antagonists Targeting the Tgf-B Pathway
Application: 16/995,428 →
Publication: US 2021/0002348
Multispecific Antagonists
Application: 63/202,262 →
Multispecific Antagonists
Application: 17/805,121 →
Publication: US 2022/0389120
Multispecific Antagonists
Application: 18/562,994 →
Publication: US 2024/0279324
DLL3 Bispecific T cell Engagers
Application: 62/968,999 →
MUC17 Bispecific T cell Engagers
Application: 62/981,048 →
Claudin 18.2 Bispecific T cell Engagers
Application: 62/991,070 →
Bispecific T cell Engagers
Application: 17/164,699 →
Publication: US 2021/0246222
Bispecific T cell Engagers
Application: 18/612,342 →
Publication: US 2024/0343827
Bispecific T Cell Engagers
Application: 19/369,942 →
Trispecific T cell Engagers
Application: 17/164,696 →
Publication: US 2021/0269551
Trispecific T cell Engagers
Application: 18/758,038 →
Publication: US 2024/0425611
Multi-Specific Molecules and Mentod of Use and Making Thereof
Application: 18/748,953 →
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 24, 2016
From: SHENG, JACKIE
To: GENSUN BIOPHARMA INC
Reel/Frame 039519/0132 →
Assignment of Assignor's Interest Feb 28, 2017
From: SHENG, JACKIE Z; LIU, BO; LIU, XUEQIAN
To: GENSUN BIOPHARMA INC.
Reel/Frame 041399/0453 →
Assignment of Assignor's Interest Apr 27, 2017
From: SHENG, JACKIE; LIU, BO; JIA, HAIQUN
To: GENSUN BIOPHARMA INC.
Reel/Frame 042169/0725 →
Assignment of Assignor's Interest Jan 17, 2018
From: SHENG, JACKIE Z.; LIU, BO; LOUCKS, EMILY
To: GENSUN BIOPHARMA INC
Reel/Frame 045083/0963 →
Assignment of Assignor's Interest May 3, 2019
From: KAROW, MARGARET; SHENG, JACKIE; LIU, BO; ZHANG, WEI
To: GENSUN BIOPHARMA, INC.
Reel/Frame 049069/0969 →
Assignment of Assignor's Interest Jul 8, 2019
From: SHENG, JACKIE; LIU, BO
To: GENSUN BIOPHARMA, INC.
Reel/Frame 049690/0633 →
Assignment of Assignor's Interest Jul 8, 2019
From: KAROW, MARGARET; SHENG, JACKIE; LIU, BO; ZHANG, WEI
To: GENSUN BIOPHARMA, INC.
Reel/Frame 049689/0582 →
Assignment of Assignor's Interest Jul 8, 2019
From: SHENG, JACKIE; LIU, BO; KAROW, MARGARET
To: GENSUN BIOPHARMA, INC.
Reel/Frame 049690/0280 →
Assignment of Assignor's Interest Jul 8, 2019
From: SHENG, JACKIE; LIU, BO; KAROW, MARGARET; ZHANG, WEI
To: GENSUN BIOPHARMA, INC.
Reel/Frame 049690/0020 →
Assignment of Assignor's Interest Dec 19, 2019
From: KAROW, MARGARET; SHENG, JACKIE; ZHANG, WEI
To: GENSUN BIOPHARMA, INC.
Reel/Frame 051333/0256 →
Assignment of Assignor's Interest Mar 18, 2020
From: SHENG, JACKIE; KAROW, MARGARET; ZHANG, WEI
To: GENSUN BIOPHARMA, INC.
Reel/Frame 052145/0223 →
Assignment of Assignor's Interest Aug 21, 2020
From: KAROW, MARGARET; SHENG, JACKIE; ZHANG, WEI
To: GENSUN BIOPHARMA, INC.
Reel/Frame 053579/0907 →
Assignment of Assignor's Interest Aug 21, 2020
From: SHENG, JACKIE; LIU, BO
To: GENSUN BIOPHARMA, INC.
Reel/Frame 053579/0877 →
Assignment of Assignor's Interest Mar 17, 2021
From: SHENG, JACKIE; LIU, BO; JIA, HAIQUN
To: GENSUN BIOPHARMA INC.
Reel/Frame 055616/0524 →
Assignment of Assignor's Interest Jul 9, 2021
From: SHENG, JACKIE; LIU, BO
To: GENSUN BIOPHARMA, INC.
Reel/Frame 056798/0821 →
Assignment of Assignor's Interest Jul 9, 2021
From: SHEN, JACKIE; LIU, BO; KAROW, MARGARET
To: GENSUN BIOPHARMA, INC.
Reel/Frame 056798/0933 →
Assignment of Assignor's Interest Jul 27, 2022
From: SHENG, JACKIE Z.; LIU, BO; LOUCKS, EMILY
To: GENSUN BIOPHARMA INC
Reel/Frame 060638/0675 →
Assignment of Assignor's Interest May 15, 2025
From: SHENG, JACKIE Z.; LIU, BO; LOUCKS, EMILY
To: GENSUN BIOPHARMA INC
Reel/Frame 071280/0921 →
Assignment of Assignor's Interest Jul 2, 2025
From: SHENG, JACKIE; KAROW, MARGARET; ZHANG, WEI
To: GENSUN BIOPHARMA, INC.
Reel/Frame 071588/0373 →
Assignment of Assignor's Interest Aug 4, 2025
From: SHENG, JACKIE; KAROW, MARGARET; ZHANG, WEI
To: GENSUN BIOPHARMA, INC.
Reel/Frame 071923/0442 →
Assignment of Assignor's Interest Dec 16, 2025
From: GENSUN BIOPHARMA INC.
To: ZELGEN HOLDINGS LIMITED
Reel/Frame 073225/0789 →